Review



cd3 negative selection kit  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Miltenyi Biotec cd3 negative selection kit
    Cd3 Negative Selection Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1181 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+negative+selection+kit/Pan+T+Cell+Isolation+Kit+II%2C+mouse/pmc11700247__BLOODA_ADV___2024___012599___mmc1-22-10-14
    Average 97 stars, based on 1181 article reviews
    cd3 negative selection kit - by Bioz Stars, 2026-10
    97/100 stars

    Images

    Related Articles

    Isolation:

    Article Title: Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration
    Article Snippet: .. T cells isolated from a CD45.1 mouse spleen using a CD3 negative selection kit (Miltenyi Biotec Inc, CA #130-095-130) were incubated on day 1 in RPMI-10% FBS media containing 1% HEPES, sodium pyruvate, NEAA, Pen/Strep and 0.05M 2-mercaptoethanol and were activated with Mouse T-Activator CD3/CD28 Dynabeads (Life Technologies,NY #11453) in the presence of IL-2 (100 U/mL, Peprotech) and IL-7 (10 ng/mL, Peprotech). .. On day 3 of ex vivo T cell culture, retroviral supernatant was spun at 2000xg for 2 hours on non-tissue culture plates coated with 20ug/mL retronectin (Takara Bio Inc, CA, # T100) and then 1.0x106/mL cells were added.

    Article Title: HLA-A*02:01-directed chimeric antigen receptor/forkhead box P3-engineered CD4+ T cells adopt a regulatory phenotype and suppress established graft-versus-host disease.
    Article Snippet: Cells bound to Dynabeads were pulled down using DynaMag (Invitrogen). .. A*02:01 CD3+ T cells from the same donor as CAR T cells (i.e., donor-matched) were isolated from PBMCs using a CD3+ negative selection kit from Miltenyi. ..

    Article Title: T cell antigenicity and immunogenicity of allogeneic exosomes
    Article Snippet: .. Antigen cross-dressing and exosome-binding assays T cells were isolated from mouse spleen, purified using a CD3-negative selection kit (Miltenyi) and cultured for 4 h with allogeneic exosomes (0, 25, 50, or 100 ug) in AIMV medium. ..

    Article Title: T cell antigenicity and immunogenicity of allogeneic exosomes
    Article Snippet: Open in a separate window FIGURE 1 Exosome isolation, quantification, and characterization. (A) To isolate exosomes from culture media, cells were eliminated at 300 g for 8 min, cell debris was removed at 1500 g for 15 min, and microvesicles were pelleted after centrifugation at 16 000 g for 30 min. Lastly, exosomes were collected after a 70-min centrifugation at 100 000 g. (B) Exosomes were counted and sized using Nanoparticle Tracking Analysis (NTA). (C) Panel C shows the linear relationship between the protein content of exosomes measured with a BCA protein assay and the number of vesicles determined using NTA. (D) MHC I Kd from BALB/c mice was detected on BALB/c exosomes and cells by western blot but was absent from negative control B6 (Kb) exosomes. (E) MHC II molecules were detected on exosomes and cells using western blot, and control exosomes were obtained from MHC II KO cells. (F) The exosomal marker TSG101 was detected by western blotting of exosome preparations from BALB/c cells, A20 B cell lymphoma cells, and control Rab27a/b double KO cells, which do not secrete exosomes. (G) The expression of exosomal surface protein markers (CD9 and CD63) as well as the costimulation marker CD86 were detected by FACS (using exosomes previously captured with beads covered with anti-CD9 antibodies). .. T cells were isolated from mouse spleen, purified using a CD3-negative selection kit (Miltenyi) and cultured for 4 h with allogeneic exosomes (0, 25, 50, or 100 ug) in AIMV medium. ..

    Selection:

    Article Title: Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration
    Article Snippet: .. T cells isolated from a CD45.1 mouse spleen using a CD3 negative selection kit (Miltenyi Biotec Inc, CA #130-095-130) were incubated on day 1 in RPMI-10% FBS media containing 1% HEPES, sodium pyruvate, NEAA, Pen/Strep and 0.05M 2-mercaptoethanol and were activated with Mouse T-Activator CD3/CD28 Dynabeads (Life Technologies,NY #11453) in the presence of IL-2 (100 U/mL, Peprotech) and IL-7 (10 ng/mL, Peprotech). .. On day 3 of ex vivo T cell culture, retroviral supernatant was spun at 2000xg for 2 hours on non-tissue culture plates coated with 20ug/mL retronectin (Takara Bio Inc, CA, # T100) and then 1.0x106/mL cells were added.

    Article Title: HLA-A*02:01-directed chimeric antigen receptor/forkhead box P3-engineered CD4+ T cells adopt a regulatory phenotype and suppress established graft-versus-host disease.
    Article Snippet: Cells bound to Dynabeads were pulled down using DynaMag (Invitrogen). .. A*02:01 CD3+ T cells from the same donor as CAR T cells (i.e., donor-matched) were isolated from PBMCs using a CD3+ negative selection kit from Miltenyi. ..

    Article Title: T cell antigenicity and immunogenicity of allogeneic exosomes
    Article Snippet: .. Antigen cross-dressing and exosome-binding assays T cells were isolated from mouse spleen, purified using a CD3-negative selection kit (Miltenyi) and cultured for 4 h with allogeneic exosomes (0, 25, 50, or 100 ug) in AIMV medium. ..

    Article Title: T cell antigenicity and immunogenicity of allogeneic exosomes
    Article Snippet: Open in a separate window FIGURE 1 Exosome isolation, quantification, and characterization. (A) To isolate exosomes from culture media, cells were eliminated at 300 g for 8 min, cell debris was removed at 1500 g for 15 min, and microvesicles were pelleted after centrifugation at 16 000 g for 30 min. Lastly, exosomes were collected after a 70-min centrifugation at 100 000 g. (B) Exosomes were counted and sized using Nanoparticle Tracking Analysis (NTA). (C) Panel C shows the linear relationship between the protein content of exosomes measured with a BCA protein assay and the number of vesicles determined using NTA. (D) MHC I Kd from BALB/c mice was detected on BALB/c exosomes and cells by western blot but was absent from negative control B6 (Kb) exosomes. (E) MHC II molecules were detected on exosomes and cells using western blot, and control exosomes were obtained from MHC II KO cells. (F) The exosomal marker TSG101 was detected by western blotting of exosome preparations from BALB/c cells, A20 B cell lymphoma cells, and control Rab27a/b double KO cells, which do not secrete exosomes. (G) The expression of exosomal surface protein markers (CD9 and CD63) as well as the costimulation marker CD86 were detected by FACS (using exosomes previously captured with beads covered with anti-CD9 antibodies). .. T cells were isolated from mouse spleen, purified using a CD3-negative selection kit (Miltenyi) and cultured for 4 h with allogeneic exosomes (0, 25, 50, or 100 ug) in AIMV medium. ..

    Incubation:

    Article Title: Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration
    Article Snippet: .. T cells isolated from a CD45.1 mouse spleen using a CD3 negative selection kit (Miltenyi Biotec Inc, CA #130-095-130) were incubated on day 1 in RPMI-10% FBS media containing 1% HEPES, sodium pyruvate, NEAA, Pen/Strep and 0.05M 2-mercaptoethanol and were activated with Mouse T-Activator CD3/CD28 Dynabeads (Life Technologies,NY #11453) in the presence of IL-2 (100 U/mL, Peprotech) and IL-7 (10 ng/mL, Peprotech). .. On day 3 of ex vivo T cell culture, retroviral supernatant was spun at 2000xg for 2 hours on non-tissue culture plates coated with 20ug/mL retronectin (Takara Bio Inc, CA, # T100) and then 1.0x106/mL cells were added.

    Purification:

    Article Title: T cell antigenicity and immunogenicity of allogeneic exosomes
    Article Snippet: .. Antigen cross-dressing and exosome-binding assays T cells were isolated from mouse spleen, purified using a CD3-negative selection kit (Miltenyi) and cultured for 4 h with allogeneic exosomes (0, 25, 50, or 100 ug) in AIMV medium. ..

    Article Title: T cell antigenicity and immunogenicity of allogeneic exosomes
    Article Snippet: Open in a separate window FIGURE 1 Exosome isolation, quantification, and characterization. (A) To isolate exosomes from culture media, cells were eliminated at 300 g for 8 min, cell debris was removed at 1500 g for 15 min, and microvesicles were pelleted after centrifugation at 16 000 g for 30 min. Lastly, exosomes were collected after a 70-min centrifugation at 100 000 g. (B) Exosomes were counted and sized using Nanoparticle Tracking Analysis (NTA). (C) Panel C shows the linear relationship between the protein content of exosomes measured with a BCA protein assay and the number of vesicles determined using NTA. (D) MHC I Kd from BALB/c mice was detected on BALB/c exosomes and cells by western blot but was absent from negative control B6 (Kb) exosomes. (E) MHC II molecules were detected on exosomes and cells using western blot, and control exosomes were obtained from MHC II KO cells. (F) The exosomal marker TSG101 was detected by western blotting of exosome preparations from BALB/c cells, A20 B cell lymphoma cells, and control Rab27a/b double KO cells, which do not secrete exosomes. (G) The expression of exosomal surface protein markers (CD9 and CD63) as well as the costimulation marker CD86 were detected by FACS (using exosomes previously captured with beads covered with anti-CD9 antibodies). .. T cells were isolated from mouse spleen, purified using a CD3-negative selection kit (Miltenyi) and cultured for 4 h with allogeneic exosomes (0, 25, 50, or 100 ug) in AIMV medium. ..

    Cell Culture:

    Article Title: T cell antigenicity and immunogenicity of allogeneic exosomes
    Article Snippet: .. Antigen cross-dressing and exosome-binding assays T cells were isolated from mouse spleen, purified using a CD3-negative selection kit (Miltenyi) and cultured for 4 h with allogeneic exosomes (0, 25, 50, or 100 ug) in AIMV medium. ..

    Article Title: T cell antigenicity and immunogenicity of allogeneic exosomes
    Article Snippet: Open in a separate window FIGURE 1 Exosome isolation, quantification, and characterization. (A) To isolate exosomes from culture media, cells were eliminated at 300 g for 8 min, cell debris was removed at 1500 g for 15 min, and microvesicles were pelleted after centrifugation at 16 000 g for 30 min. Lastly, exosomes were collected after a 70-min centrifugation at 100 000 g. (B) Exosomes were counted and sized using Nanoparticle Tracking Analysis (NTA). (C) Panel C shows the linear relationship between the protein content of exosomes measured with a BCA protein assay and the number of vesicles determined using NTA. (D) MHC I Kd from BALB/c mice was detected on BALB/c exosomes and cells by western blot but was absent from negative control B6 (Kb) exosomes. (E) MHC II molecules were detected on exosomes and cells using western blot, and control exosomes were obtained from MHC II KO cells. (F) The exosomal marker TSG101 was detected by western blotting of exosome preparations from BALB/c cells, A20 B cell lymphoma cells, and control Rab27a/b double KO cells, which do not secrete exosomes. (G) The expression of exosomal surface protein markers (CD9 and CD63) as well as the costimulation marker CD86 were detected by FACS (using exosomes previously captured with beads covered with anti-CD9 antibodies). .. T cells were isolated from mouse spleen, purified using a CD3-negative selection kit (Miltenyi) and cultured for 4 h with allogeneic exosomes (0, 25, 50, or 100 ug) in AIMV medium. ..



    Similar Products

    90
    IPHASE Biosciences Inc mouse cd3 + t cells negative selection kit
    Mouse Cd3 + T Cells Negative Selection Kit, supplied by IPHASE Biosciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+negative+selection+kit/mouse+pbmc+isolation+kit/pmc11982056-146-8-16
    Average 90 stars, based on 1 article reviews
    mouse cd3 + t cells negative selection kit - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    STEMCELL Technologies Inc cd3 negative selection kit
    A comparison of cellular compositions in allografts, lymphoma autografts and MM autografts. The percentages of CD34 + stem cells, CD33 + CD14 + CD15 − HLA-DR −/low M-MDSC, CD33 + CD14 − CD15 + PMN-MDSC, CD33 + CD14 − CD15 − HLA-DR − e-MDSC, <t>CD3</t> + T, CD3 − CD56 + NK, CD3 + CD56 + NKT, CD3 + CD56 − TCRαβ + CD4 − CD8 − DNTreg, CD3 + CD4 + CD25 + Foxp3 + Treg, CD19 + B cells, and CD14 + HLA-DR hi conventional monocytes in the grafts were evaluated by staining the graft cells using fluorescence labeled antibodies and analyzed by Flowjo software. ( A ) Percentages of cell subsets in the grafts. ( B ) Infusion dose of cell subsets in the grafts. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
    Cd3 Negative Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+negative+selection+kit/cd4+negative+selection+kit/pmc11429538-80-11-20
    Average 90 stars, based on 1 article reviews
    cd3 negative selection kit - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec cd3 negative selection kit
    A comparison of cellular compositions in allografts, lymphoma autografts and MM autografts. The percentages of CD34 + stem cells, CD33 + CD14 + CD15 − HLA-DR −/low M-MDSC, CD33 + CD14 − CD15 + PMN-MDSC, CD33 + CD14 − CD15 − HLA-DR − e-MDSC, <t>CD3</t> + T, CD3 − CD56 + NK, CD3 + CD56 + NKT, CD3 + CD56 − TCRαβ + CD4 − CD8 − DNTreg, CD3 + CD4 + CD25 + Foxp3 + Treg, CD19 + B cells, and CD14 + HLA-DR hi conventional monocytes in the grafts were evaluated by staining the graft cells using fluorescence labeled antibodies and analyzed by Flowjo software. ( A ) Percentages of cell subsets in the grafts. ( B ) Infusion dose of cell subsets in the grafts. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
    Cd3 Negative Selection Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+negative+selection+kit/Pan+T+Cell+Isolation+Kit+II%2C+mouse/pmc11700247__BLOODA_ADV___2024___012599___mmc1-22-10-14
    Average 97 stars, based on 1 article reviews
    cd3 negative selection kit - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    90
    STEMCELL Technologies Inc human cd3-negative and cd56-positive selection kits
    A comparison of cellular compositions in allografts, lymphoma autografts and MM autografts. The percentages of CD34 + stem cells, CD33 + CD14 + CD15 − HLA-DR −/low M-MDSC, CD33 + CD14 − CD15 + PMN-MDSC, CD33 + CD14 − CD15 − HLA-DR − e-MDSC, <t>CD3</t> + T, CD3 − CD56 + NK, CD3 + CD56 + NKT, CD3 + CD56 − TCRαβ + CD4 − CD8 − DNTreg, CD3 + CD4 + CD25 + Foxp3 + Treg, CD19 + B cells, and CD14 + HLA-DR hi conventional monocytes in the grafts were evaluated by staining the graft cells using fluorescence labeled antibodies and analyzed by Flowjo software. ( A ) Percentages of cell subsets in the grafts. ( B ) Infusion dose of cell subsets in the grafts. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
    Human Cd3 Negative And Cd56 Positive Selection Kits, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+negative+selection+kit/easysep+human+t+cell+isolation+kit/pmc11143278-286-9-12
    Average 90 stars, based on 1 article reviews
    human cd3-negative and cd56-positive selection kits - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    STEMCELL Technologies Inc cd3-negative cd56-positive selection kits
    A comparison of cellular compositions in allografts, lymphoma autografts and MM autografts. The percentages of CD34 + stem cells, CD33 + CD14 + CD15 − HLA-DR −/low M-MDSC, CD33 + CD14 − CD15 + PMN-MDSC, CD33 + CD14 − CD15 − HLA-DR − e-MDSC, <t>CD3</t> + T, CD3 − CD56 + NK, CD3 + CD56 + NKT, CD3 + CD56 − TCRαβ + CD4 − CD8 − DNTreg, CD3 + CD4 + CD25 + Foxp3 + Treg, CD19 + B cells, and CD14 + HLA-DR hi conventional monocytes in the grafts were evaluated by staining the graft cells using fluorescence labeled antibodies and analyzed by Flowjo software. ( A ) Percentages of cell subsets in the grafts. ( B ) Infusion dose of cell subsets in the grafts. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
    Cd3 Negative Cd56 Positive Selection Kits, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+negative+selection+kit/rosette+sep/ppr0740097-87-5-13
    Average 90 stars, based on 1 article reviews
    cd3-negative cd56-positive selection kits - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    STEMCELL Technologies Inc pan naïve cd3+ negative selection kit
    A comparison of cellular compositions in allografts, lymphoma autografts and MM autografts. The percentages of CD34 + stem cells, CD33 + CD14 + CD15 − HLA-DR −/low M-MDSC, CD33 + CD14 − CD15 + PMN-MDSC, CD33 + CD14 − CD15 − HLA-DR − e-MDSC, <t>CD3</t> + T, CD3 − CD56 + NK, CD3 + CD56 + NKT, CD3 + CD56 − TCRαβ + CD4 − CD8 − DNTreg, CD3 + CD4 + CD25 + Foxp3 + Treg, CD19 + B cells, and CD14 + HLA-DR hi conventional monocytes in the grafts were evaluated by staining the graft cells using fluorescence labeled antibodies and analyzed by Flowjo software. ( A ) Percentages of cell subsets in the grafts. ( B ) Infusion dose of cell subsets in the grafts. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
    Pan Naïve Cd3+ Negative Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+negative+selection+kit/pan+na%C3%AFve+cd3++negative+selection+kit/pm37321403-291-17-23
    Average 90 stars, based on 1 article reviews
    pan naïve cd3+ negative selection kit - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    STEMCELL Technologies Inc negative selection kit cd3+cd4+cd45ra-cd45ro+ cells
    A comparison of cellular compositions in allografts, lymphoma autografts and MM autografts. The percentages of CD34 + stem cells, CD33 + CD14 + CD15 − HLA-DR −/low M-MDSC, CD33 + CD14 − CD15 + PMN-MDSC, CD33 + CD14 − CD15 − HLA-DR − e-MDSC, <t>CD3</t> + T, CD3 − CD56 + NK, CD3 + CD56 + NKT, CD3 + CD56 − TCRαβ + CD4 − CD8 − DNTreg, CD3 + CD4 + CD25 + Foxp3 + Treg, CD19 + B cells, and CD14 + HLA-DR hi conventional monocytes in the grafts were evaluated by staining the graft cells using fluorescence labeled antibodies and analyzed by Flowjo software. ( A ) Percentages of cell subsets in the grafts. ( B ) Infusion dose of cell subsets in the grafts. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
    Negative Selection Kit Cd3+Cd4+Cd45ra Cd45ro+ Cells, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3+negative+selection+kit/na%C3%AFve+primary+human+t+cells++cd3++++cd4++++cd45ra+/pm37438188-77-20-22
    Average 90 stars, based on 1 article reviews
    negative selection kit cd3+cd4+cd45ra-cd45ro+ cells - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    A comparison of cellular compositions in allografts, lymphoma autografts and MM autografts. The percentages of CD34 + stem cells, CD33 + CD14 + CD15 − HLA-DR −/low M-MDSC, CD33 + CD14 − CD15 + PMN-MDSC, CD33 + CD14 − CD15 − HLA-DR − e-MDSC, CD3 + T, CD3 − CD56 + NK, CD3 + CD56 + NKT, CD3 + CD56 − TCRαβ + CD4 − CD8 − DNTreg, CD3 + CD4 + CD25 + Foxp3 + Treg, CD19 + B cells, and CD14 + HLA-DR hi conventional monocytes in the grafts were evaluated by staining the graft cells using fluorescence labeled antibodies and analyzed by Flowjo software. ( A ) Percentages of cell subsets in the grafts. ( B ) Infusion dose of cell subsets in the grafts. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

    Journal: Cells

    Article Title: The Interactions of T Cells with Myeloid-Derived Suppressor Cells in Peripheral Blood Stem Cell Grafts

    doi: 10.3390/cells13181545

    Figure Lengend Snippet: A comparison of cellular compositions in allografts, lymphoma autografts and MM autografts. The percentages of CD34 + stem cells, CD33 + CD14 + CD15 − HLA-DR −/low M-MDSC, CD33 + CD14 − CD15 + PMN-MDSC, CD33 + CD14 − CD15 − HLA-DR − e-MDSC, CD3 + T, CD3 − CD56 + NK, CD3 + CD56 + NKT, CD3 + CD56 − TCRαβ + CD4 − CD8 − DNTreg, CD3 + CD4 + CD25 + Foxp3 + Treg, CD19 + B cells, and CD14 + HLA-DR hi conventional monocytes in the grafts were evaluated by staining the graft cells using fluorescence labeled antibodies and analyzed by Flowjo software. ( A ) Percentages of cell subsets in the grafts. ( B ) Infusion dose of cell subsets in the grafts. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

    Article Snippet: CD3 + T cells were sorted from the grafts using a CD3 negative selection kit according to the manufacturer’s protocol (StemCell Technologies, Vancouver, BC, Canada).

    Techniques: Comparison, Staining, Fluorescence, Labeling, Software

    Characterization of T cells in the grafts. To evaluate the percentages of naïve, effector or memory T cells, fluorescence-labeled antibodies against CD45RA and CCR7 were added into the staining panel. To evaluate the proliferation and cytokine secretion of T cells in the grafts, sorted CD3 + T cells from allografts and autografts were cultured for 5 days and then were stained with Ki67 to evaluate T cell proliferation, with fluorescence-labeled anti-IFN-γ for cytokine secretion. The expression of inhibitory receptors PD-1, CTLA-4, TIM-3, LAG-3, TIGIT and BTLA on CD4 + T and CD8 + T cells were evaluated by staining the graft cells using fluorescence-labeled antibodies. ( A ) Percentages of naïve, effector, central memory and effector memory T cells in the grafts. ( B ) The expression levels of Ki67 and IFN-γ in CD3 + T cells of 10 allografts, 9 lymphoma autografts and 10 MM autografts. ( C ) The expression pattern of inhibitory receptors on T cells in the grafts. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

    Journal: Cells

    Article Title: The Interactions of T Cells with Myeloid-Derived Suppressor Cells in Peripheral Blood Stem Cell Grafts

    doi: 10.3390/cells13181545

    Figure Lengend Snippet: Characterization of T cells in the grafts. To evaluate the percentages of naïve, effector or memory T cells, fluorescence-labeled antibodies against CD45RA and CCR7 were added into the staining panel. To evaluate the proliferation and cytokine secretion of T cells in the grafts, sorted CD3 + T cells from allografts and autografts were cultured for 5 days and then were stained with Ki67 to evaluate T cell proliferation, with fluorescence-labeled anti-IFN-γ for cytokine secretion. The expression of inhibitory receptors PD-1, CTLA-4, TIM-3, LAG-3, TIGIT and BTLA on CD4 + T and CD8 + T cells were evaluated by staining the graft cells using fluorescence-labeled antibodies. ( A ) Percentages of naïve, effector, central memory and effector memory T cells in the grafts. ( B ) The expression levels of Ki67 and IFN-γ in CD3 + T cells of 10 allografts, 9 lymphoma autografts and 10 MM autografts. ( C ) The expression pattern of inhibitory receptors on T cells in the grafts. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

    Article Snippet: CD3 + T cells were sorted from the grafts using a CD3 negative selection kit according to the manufacturer’s protocol (StemCell Technologies, Vancouver, BC, Canada).

    Techniques: Fluorescence, Labeling, Staining, Cell Culture, Expressing

    Morphology and immune regulatory function of M-MDSCs in the allografts, lymphoma and MM autografts. M-MDSCs were sorted from allografts, lymphoma and MM autografts using flow cytometer based on cell surface markers. The morphology of M-MDSCs was evaluated by HEMA-3 staining and then read via microscopy (200× magnification). By using CD3 negative selection kit, CD3 + T cells were sorted from peripheral blood of third-party healthy donors or from PBSCs grafts of lymphoma or multiple myeloma patients. CD3 + T cells were co-cultured with M-MDSCs at different ratios in the presence of anti-CD3/CD28 for 4–5 days. T cell proliferation, IFN-γ secretion and Treg expansion were evaluated. ( A ) Morphology and immune regulatory function of M-MDSCs sorted from allograft on third-party T cell proliferation, IFN-γ secretion and CD4 + CD25 + Foxp3 + Treg expansion. ( B ) Morphology and immune regulatory function of M-MDSCs sorted from lymphoma autograft on autologous T cell proliferation, IFN-γ secretion and autologous CD4 + CD25 + Foxp3 + Treg expansion. ( C ) Morphology and immune regulatory function of M-MDSCs sorted from MM autograft on autologous T cell proliferation and IFN-γ secretion. ( D ) Comparison of suppressive function of M-MDSCs sorted from allograft or autograft against the same third-party healthy donor T cells at a ratio of T:M-MDSC (1:0.4). *, p < 0.05; **, p < 0.01; ***, p < 0.001. These results represent one of two to three independent experiments.

    Journal: Cells

    Article Title: The Interactions of T Cells with Myeloid-Derived Suppressor Cells in Peripheral Blood Stem Cell Grafts

    doi: 10.3390/cells13181545

    Figure Lengend Snippet: Morphology and immune regulatory function of M-MDSCs in the allografts, lymphoma and MM autografts. M-MDSCs were sorted from allografts, lymphoma and MM autografts using flow cytometer based on cell surface markers. The morphology of M-MDSCs was evaluated by HEMA-3 staining and then read via microscopy (200× magnification). By using CD3 negative selection kit, CD3 + T cells were sorted from peripheral blood of third-party healthy donors or from PBSCs grafts of lymphoma or multiple myeloma patients. CD3 + T cells were co-cultured with M-MDSCs at different ratios in the presence of anti-CD3/CD28 for 4–5 days. T cell proliferation, IFN-γ secretion and Treg expansion were evaluated. ( A ) Morphology and immune regulatory function of M-MDSCs sorted from allograft on third-party T cell proliferation, IFN-γ secretion and CD4 + CD25 + Foxp3 + Treg expansion. ( B ) Morphology and immune regulatory function of M-MDSCs sorted from lymphoma autograft on autologous T cell proliferation, IFN-γ secretion and autologous CD4 + CD25 + Foxp3 + Treg expansion. ( C ) Morphology and immune regulatory function of M-MDSCs sorted from MM autograft on autologous T cell proliferation and IFN-γ secretion. ( D ) Comparison of suppressive function of M-MDSCs sorted from allograft or autograft against the same third-party healthy donor T cells at a ratio of T:M-MDSC (1:0.4). *, p < 0.05; **, p < 0.01; ***, p < 0.001. These results represent one of two to three independent experiments.

    Article Snippet: CD3 + T cells were sorted from the grafts using a CD3 negative selection kit according to the manufacturer’s protocol (StemCell Technologies, Vancouver, BC, Canada).

    Techniques: Flow Cytometry, Staining, Microscopy, Selection, Cell Culture, Comparison

    M-MDSCs drive CD8 + T cell exhaustion. M-MDSCs sorted from lymphoma autograft were co-cultured with sorted autologous CD3 + T cells in the presence of anti-CD3/CD28 for 4–5 days. The T cell proliferation, expression of PD-1 and IFN-γ on CD8 + T cells and CD4 + T cells were evaluated. To block the interaction of PD-L1 with PD-1, anti-PD-L1 (10 μg/mL) was added into the co-culture system at the beginning. ( A ) The representative figures of expression of PD-1 and IFN-γ on CD8 + T cells. ( B ) Effects of M-MDSCs on autologous T cell proliferation, effector T expansion and PD-1 expression. ( C ) The effects of anti-PD-L1 on the suppressive function of M-MDSCs sorted from lymphoma autograft. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

    Journal: Cells

    Article Title: The Interactions of T Cells with Myeloid-Derived Suppressor Cells in Peripheral Blood Stem Cell Grafts

    doi: 10.3390/cells13181545

    Figure Lengend Snippet: M-MDSCs drive CD8 + T cell exhaustion. M-MDSCs sorted from lymphoma autograft were co-cultured with sorted autologous CD3 + T cells in the presence of anti-CD3/CD28 for 4–5 days. The T cell proliferation, expression of PD-1 and IFN-γ on CD8 + T cells and CD4 + T cells were evaluated. To block the interaction of PD-L1 with PD-1, anti-PD-L1 (10 μg/mL) was added into the co-culture system at the beginning. ( A ) The representative figures of expression of PD-1 and IFN-γ on CD8 + T cells. ( B ) Effects of M-MDSCs on autologous T cell proliferation, effector T expansion and PD-1 expression. ( C ) The effects of anti-PD-L1 on the suppressive function of M-MDSCs sorted from lymphoma autograft. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

    Article Snippet: CD3 + T cells were sorted from the grafts using a CD3 negative selection kit according to the manufacturer’s protocol (StemCell Technologies, Vancouver, BC, Canada).

    Techniques: Cell Culture, Expressing, Blocking Assay, Co-Culture Assay

    Morphology and immune regulatory function of PMN-MDSCs in the allografts, lymphoma and MM autografts. The morphology of sorted PMN-MDSCs was evaluated by HEMA-3 staining and then read via microscopy (200× magnification). The CD3 + T cells sorted from healthy third-party donor or autologous donor were co-cultured with PMN-MDSCs at different ratios in the presence of anti-CD3/CD28 for 4–5 days. T cell proliferation, IFN-γ secretion and Treg expansion were evaluated. ( A ) Morphology and immune regulatory function of PMN-MDSCs sorted from allograft on third-party T cell proliferation, IFN-γ secretion and CD4 + CD25 + Foxp3 + Treg expansion. ( B ) Morphology and immune regulatory function of PMN-MDSCs sorted from lymphoma autograft on T cell proliferation, IFN-γ secretion and CD4 + CD25 + Foxp3 + Treg expansion. ( C ) Morphology and immune regulatory function of PMN-MDSCs sorted from MM autograft on T cell proliferation and IFN-γ secretion. ( D ) Comparison of the suppressive function of M-MDSCs and PMN-MDSCs from the same graft at a ratio of T:M-MDSC (1:0.4). These results represent one of two to three independent experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

    Journal: Cells

    Article Title: The Interactions of T Cells with Myeloid-Derived Suppressor Cells in Peripheral Blood Stem Cell Grafts

    doi: 10.3390/cells13181545

    Figure Lengend Snippet: Morphology and immune regulatory function of PMN-MDSCs in the allografts, lymphoma and MM autografts. The morphology of sorted PMN-MDSCs was evaluated by HEMA-3 staining and then read via microscopy (200× magnification). The CD3 + T cells sorted from healthy third-party donor or autologous donor were co-cultured with PMN-MDSCs at different ratios in the presence of anti-CD3/CD28 for 4–5 days. T cell proliferation, IFN-γ secretion and Treg expansion were evaluated. ( A ) Morphology and immune regulatory function of PMN-MDSCs sorted from allograft on third-party T cell proliferation, IFN-γ secretion and CD4 + CD25 + Foxp3 + Treg expansion. ( B ) Morphology and immune regulatory function of PMN-MDSCs sorted from lymphoma autograft on T cell proliferation, IFN-γ secretion and CD4 + CD25 + Foxp3 + Treg expansion. ( C ) Morphology and immune regulatory function of PMN-MDSCs sorted from MM autograft on T cell proliferation and IFN-γ secretion. ( D ) Comparison of the suppressive function of M-MDSCs and PMN-MDSCs from the same graft at a ratio of T:M-MDSC (1:0.4). These results represent one of two to three independent experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

    Article Snippet: CD3 + T cells were sorted from the grafts using a CD3 negative selection kit according to the manufacturer’s protocol (StemCell Technologies, Vancouver, BC, Canada).

    Techniques: Staining, Microscopy, Cell Culture, Comparison